Recombinant human interleukin-1A (rhIL-1A) is a potent mediator with significant roles in inflammatory and immune responses. Due to its diverse biological activities, rhIL-1A has emerged as a promising therapeutic target for a variety of ailments. Characterization of rhIL-1A is crucial for understanding its mechanisms of action and optimizing its e